Search Results - Wen-Juan Miao

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study

    Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study by Ji-Xin Tian, Ping Zhang, Xiao-Xu Wang, Jin-Wen Li, Dong-Xue Liu, Yi-Ying Liu, Zhi-Jian Xiao, Wen-Juan Miao

    Published 2025-07-01

    BackgroundVenetoclax (VEN), an orally bioavailable B-cell lymphoma-2 inhibitor, shows promising activity in patients with myelodysplastic syndromes (MDS) when combined with hypomethylating agents (HMAs). However, research regarding the VEN exposure in Chinese patients with MDS remains notably sparse...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: